Pulmonary Cell News Volume 15.21 | Nov 5 2026

    0
    12








    2026-11-05 | PULCN 15.21


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 15.21 – 05 November, 2026
    TOP STORY

    Methylated eEF1A Selectively Decodes mRNA to Shape Cancer Proteomes

    Investigators showed that methyltransferase-like protein 13-catalyzed dimethylation of the elongation factor eukaryotic translation elongation factor 1α (eEF1A) at lysine 55 enhances decoding of select codons, preferentially increasing pro-oncogenic protein synthesis to promote tumorigenesis.
    [Nature Cell Biology]

    Full Article
    Request your free EasySepâ„¢ sample and get a pair of highly coveted science socks.
    PUBLICATIONSListed by the impact factor of the journal

    VAPA-Dependent Lipid Transport at ER-Lamellar Body Contact Sites Promotes Human Lung Surfactant Formation

    Researchers identified the pulmonary disease-associated ATP-binding cassette transporter A3, a regulator of surfactant lipid accumulation, as a vesicle-associated membrane protein-associated protein A (VAPA) interactor.
    [Developmental Cell]

    Full Article | Graphical Abstract

    Atmospheric Aging Modifies the Toxicological Profile of Biomass Burning Particles in Epithelial Lung Cells

    By combining realistic long-term atmospheric aging with direct comparison of fresh and aged particles, scientists provided a uniquely controlled framework to assess how chemical aging reshapes epithelial stress and immune responses.
    [Environmental Science & Technology]

    Full Article | Graphical Abstract

    Early-Life Cigarette Smoke Exposure Predisposes to COPD by Suppressing the HAS2-TGF-B1-MAPK Axis in Lung Fibroblasts

    Using comparative cigarette smoke (CS) exposure in neonatal and adult mice, investigators showed that early‑life CS produces fundamentally different pathology from adult exposure.
    [Ecotoxicology and Environmental Safety]

    Full Article | Graphical Abstract

    FOXM1/LncRNA COPD-R Regulates Pulmonary Inflammation in Chronic Obstructive Pulmonary Disease Induced by Biomass-Related PM2.5

    The authors investigated the role of the forkhead box M1 (FOXM1)/long noncoding RNA (lncRNA) COPD-R axis in biomass-related particulate matter (PM)2.5-induced pulmonary inflammatory responses.
    [Ecotoxicology and Environmental Safety]

    Full Article | Graphical Abstract

    p97 Inhibition Attenuates Cigarette Smoke-Induced Lung Inflammation and Epithelial Senescence by Restoring SIRT1 SUMOylation

    Scientists investigated the role of AAA+ ATPase p97 in regulating sirtuin 1 (SIRT1) post-translational modification and its contribution to pulmonary pathology.
    [Biochemical Pharmacology]

    Abstract | Graphical Abstract

    Mechanistic Insight into circDDRC Aggravated Cadmium-Induced DNA Damage: Sponging miR-199a-5p to Target PTEN and Suppress PI3K-Dependent Homologous Recombination Repair

    Researchers identified a novel circular RNA, designated as circDNA-Damage-Regulator-by-cadmium (DDRC), and demonstrated its significant association with DNA damage through integrated analyses of occupational cohorts, in vivo animal models, and in vitro cellular assays.
    [Chemico-Biological Interactions]

    Abstract | Graphical Abstract

    Epigenetic Targeting of an HBO1-H3K9la-CHI3L1 Axis Reduces Regulatory B Cell-Mediated CD8+ T Cell Dysfunction in Lung Adenocarcinoma

    The authors intended to examine the role of glycolysis in LUAD growth and immunosuppression and to explore the underpinning mechanisms.
    [Journal for Immunotherapy of Cancer]

    Full Article

    The Metabolic Dependency on GLUT3 Mediates Smoking-Induced NSCLC Progression

    Scientists investigated the clinical relevance, regulatory mechanisms, and therapeutic potential of glucose metabolism in smoking-associated NSCLC.
    [Cancer Letters]

    Abstract

    β-Elemene Suppressed EMT via IGF1R Inhibition in Osimertinib Treated AXL Low-Expressing EGFR Mutant Non-Small Cell Lung Cancer

    Researchers observed the antitumor effect of osimertinib combined with the IGF1R inhibitor β-elemene in two EGFR mutant cell lines, both harboring AXL-low expression, and an orthotopic NSCLC nude mouse model.
    [European Journal of Pharmacology]

    Abstract | Graphical Abstract

    13β,21-Dihydroeurycomanone Induces Pyroptosis in Lung Adenocarcinoma Cells via Activating RIG-1/Caspase-1/GSDMD Pathway

    Scientists aimed to investigate the role of 13β,21-dihydroeurycomanone (DHEN) in the pyroptosis of LUAD cells and found that DHEN significantly inhibited the proliferation of two LUAD cell lines, but had no obvious cytotoxic effects on normal human bronchial epithelial cells.
    [European Journal of Pharmacology]

    Abstract | Graphical Abstract
    Two cartoon scientists talking animatedly to each other to represent leaders in scientific communication
    REVIEWS

    The Evolving Landscape of DLL3-Directed Therapeutics in Small Cell Lung Cancer

    The authors critically examine the evolving portfolio of delta-like ligand 3 (DLL3)-targeted therapies, a ligand aberrantly overexpressed on the surface of SCLC tumor cells, across three principal modalities.
    [Cancer Treatment Reviews]

    Full Article

    Immune Checkpoint Inhibitor Therapy in COPD-Concomitant Lung Cancer: A Review of Efficacy Outcomes and Mechanistic Insights

    Investigators synthesize clinical evidence on the efficacy of immune checkpoint inhibition, currently the most widely used immunotherapy, in lung cancer patients concomitant with COPD and elucidate potential immunological and molecular mechanisms underlying observed clinical benefits.
    [Cancer Letters]

    Abstract

    PROTAC-Induced Protein Degradation in Lung Cancer

    The authors systematically summarize recent advances in proteolysis-targeting chimera (PROTAC) technology for lung cancer, emphasizing its efficacy against key oncogenic drivers and reactivating apoptosis.
    [Chinese Medical Journal]

    Full Article
    INDUSTRY AND POLICY NEWS

    Merck Initiates Phase III Study Evaluating OHTUVAYRE® (Ensifentrine) for the Prevention of COPD Exacerbations in Adult Patients Receiving Standard of Care with a History of Exacerbations

    Merck announced the initiation of ENHANCE-3, a Phase III randomized clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of COPD exacerbations in adult patients receiving standard of care with a history of exacerbations.
    [Merck]

    Press Release
    FEATURED EVENT

    RNA at the Bench and Bedside V

    December 8-10, 2026
    La Jolla, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Technician – Lung-Brain Communication

    Howard Hughes Medical Institute – Ashburn, Virginia, United States

    Tenured and Tenure-Track Research Faculty Positions – Department of Molecular and Human Genetics

    Baylor College of Medicine – Houston, Texas, United States

    Postdoctoral Fellow – Genome Engineering

    The Icahn School of Medicine at Mount Sinai – New York City, New York, United States

    Assistant, Associate or Full Professor – Nuclear Medicine and Theranostics, Radiological Sciences, Oncology

    University of California Los Angeles – Los Angeles, California, United States

    Proteomics Specialist – Structural Proteomics

    Human Technopole – Milan, Italy

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2


    1618 Station Street

    Vancouver, BC, V6A 1B6, Canada

    Unsubscribe or manage your subscriptions.

    View the Science News privacy policy here.